Immunomic疗法
集合包含Immunomic治疗专家
专家集合是analyst-curated列表,突出了公司你需要知道的最重要的技术空间。
Immunomic疗法是包含在1专家收集,包括生物制药技术。
生物制药技术
15535件
公司参与研究、开发和商业化的化学或生物衍生& theranostic治疗药物。不包括维生素/补充剂,横/临床试验服务。
最新的Immunomic疗法新闻
2023年5月16日
|辉瑞公司,Immunomic疗法新闻由本文人类DNA疫苗市场份额提供西雅图,华盛顿,印度,2023年5月16日/ EINPresswire.com——连贯的市场见解发表了一份新的报告在2023年人类DNA疫苗市场包括基于竞争对手的详细分析和重要的细分市场。全球人类DNA疫苗市场研究报告提供了一个关键的分析市场地位的人类DNA疫苗与最好的事实和数字,意义,定义,SWOT分析,专家们的意见,在全球范围内的最新发展。该报告还计算市场规模、销售、价格、收入、毛利率、市场份额,成本结构和增长速度。该报告认为这份报告的收入产生的销售和技术通过各种应用程序段和反刍市场数据表。研究提供了非常详细地分成几个方面,研究了市场增长轨迹。研究还确定了全球市场的挑战,面临人类DNA疫苗。人类的DNA疫苗市场报告涵盖了不同的市场情况,直接影响市场的增长。人类DNA疫苗研究报告包括市场因素如市场动态信息,包括司机、限制,挑战,威胁,和潜在的增长机会,市场趋势,发展模式、财务信息,最新技术,创新,领先竞争对手,和区域市场的分析。最关键球员在痴呆药物市场报告:顶级公司与人类DNA疫苗市场:葛兰素史克,印度血清研究所pvt Ltd .)巴拉特生物技术。,我ndian Immunologicals Limited, Merck & Co., Inc., GREEN CROSS CORP, Novartis AG, Sanofi, Zoetis, Aldevron, AnGes, Inc., Pfizer Inc., Immunomic Therapeutics, Inc., Inovio Pharmaceuticals, Inc., General Electric, Ichor Medical Systems., VGXI, Inc., Biomay AG, Valneva SE, and GeoVax Request for A Sample Copy Here! Key Benefits For Stakeholders: ☯ This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the Human DNA Vaccines market analysis from 2023 to 2030 to identify the prevailing Human DNA Vaccines market opportunities. ☯ The market research is offered along with information related to key drivers, restraints, and opportunities. ☯ Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network. ☯ In-depth analysis of the Human DNA Vaccines market segmentation assists to determine the prevailing market opportunities. ☯ Major countries in each region are mapped according to their revenue contribution to the global market. ☯ Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players. ☯ The report includes the analysis of the regional as well as global Human DNA Vaccines market trends, key players, market segments, application areas, and market growth strategies. Segmentation of Human DNA Vaccines Market: By Type Why Coherent Market Insights? ✦ Targeted Marketing Strategies- We help businesses analyze the competition, including strengths, weaknesses, and market share to develop effective marketing strategies and gain a competitive advantage. ✦ Innovative Solutions- We helps businesses identify new market opportunities and potential areas for growth. This includes new customer segments, emerging trends, and untapped markets. ✦ Continuous Learning- CMI provides businesses with objective data and insights that can inform decision making. This can lead to more effective and successful business strategies. ✦ Strong Market Research Expertise- Coherent Market Insights helps businesses understand the target market, including customer preferences, needs, and behaviors to meet customer demands, leading to higher sales and customer satisfaction. ✦ Strong Customer Service- By our Company your businesses can minimize the risk of launching new products or services that may not resonate with your target market. Mr. Shah +1 206-701-6702
Immunomic疗法常见问题(FAQ)
Immunomic疗法是何时成立的?
Immunomic疗法成立于2005年。
Immunomic疗法的总部在哪里?
Immunomic疗法的总部位于Broschart路15010号,罗克维尔市。
Immunomic疗法的最新一轮融资是什么?
Immunomic疗法的最新一轮融资是企业少数- IV。
Immunomic疗法筹集了多少钱?
Immunomic疗法提出总计142.06美元。
Immunomic疗法的投资者是谁?
Immunomic疗法的投资者包括HLB、薪水保护计划,下一个科学,生命科学温室宾夕法尼亚州中部,集团公司论坛和8。
Immunomic疗法的竞争对手是谁?
Immunomic疗法的竞争对手包括Igenica Biotherapeutics, Nps制药、MabVax疗法,命运NovaDigm疗法,治疗和10。
竞争对手比较Immunomic疗法
Neomics药物发现和诊断公司与一个独特的癌症和生物标志物发现目标平台。特别是,Neomics关注相关的新靶点和生物标志物氨酰基RNA合成酶(ARS)。他们有目标和生物标志物的临床前和临床验证。
Traversa疗法是一个生物制药公司从事发现,RNAi抗癌疗法的发展和商业化。公司力求迅速推进短干扰RNA (siRNA)平台交付技术使用的RNAi治疗公司针对各种急性、慢性和人类传染性疾病。Traversa关注平台交付技术的优化,以及促进治疗白血病和恶性胶质瘤的治疗程序。
NanoMedica旨在成为从事设计、开发和制造的双重作用疗法用于治疗人类癌症。
Eximias发展晚期癌症疗法。Eximias现在的全资子公司YM名叫YM美国生物科学
猎鹰基因组学公司专注于功能基因组学作为癌症诊断和治疗的工具。
Intarcia疗法是一家生物制药公司。它从事开发的管道产品的专有美第奇药物输送系统由三个技术:稳定技术,允许蛋白质、多肽、抗体片段,和其他高度有效的小分子是稳定在或高于人体温度,一个matchstick-sized渗透mini-pump放置在皮肤的真皮层提供一个连续和一致的药物和放置技术包括专有工具旨在提供最优的用户体验。公司成立于1995年,总部设在波士顿,马萨诸塞州。